Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NJ › HACKETTSTOWN › AHS HOSPITAL CORP

AHS HOSPITAL CORP

NPI: 1518969419 · HACKETTSTOWN, NJ 07840 · General Acute Care Hospital · NPI assigned 08/11/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WALTER, JOSEPH controls 12+ related entities in our dataset. Read more

$16.26M
Total Medicaid Paid
322,739
Total Claims
226,017
Beneficiaries
174
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWALTER, JOSEPH (SVP, CHIEF FINANCIAL OFFICER)
NPI Enumeration Date08/11/2005

Related Entities

Other providers sharing the same authorized official: WALTER, JOSEPH

ProviderCityStateTotal Paid
AHS HOSPITAL CORP. MORRISTOWN NJ $155.87M
AHS HOSPITAL CORP. SUMMIT NJ $125.20M
AHS HOSPITAL CORP. POMPTON PLAINS NJ $36.23M
AHS HOSPITAL CORP NEWTON NJ $33.62M
AHS HOSPITAL CORP. MORRISTOWN NJ $5.20M
AHS HOSPITAL CORP. NEWTON NJ $4.82M
AHS HOSPITAL CORP. NEWTON NJ $1.26M
AHS HOSPITAL CORP MORRISTOWN NJ $171K
AHS HOSPITAL CORP. MORRISTOWN NJ $1K
AHS HOSPITAL CORP. MORRISTOWN NJ $1K
AHS HOSPITAL CORP. MORRISTOWN NJ $708.57
AHS HOSPITAL CORP MORRISTOWN NJ $149.55

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 35,031 $1.41M
2019 31,994 $1.41M
2020 34,872 $1.85M
2021 42,228 $2.40M
2022 58,433 $3.10M
2023 67,871 $3.23M
2024 52,310 $2.86M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 11,027 10,277 $2.75M
99284 Emergency department visit for the evaluation and management, high severity 7,972 7,265 $2.27M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 5,040 4,554 $1.49M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,327 2,157 $1.15M
G0378 Hospital observation service, per hour 1,816 895 $792K
0202U Oncology (prostate), multianalyte, gene expression profiling 5,055 4,613 $713K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 19,454 4,170 $645K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 543 512 $602K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 12,524 2,978 $595K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,115 2,322 $424K
96375 Therapeutic injection; each additional sequential IV push 4,719 3,454 $411K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,700 3,550 $375K
70450 Computed tomography, head or brain; without contrast material 2,650 2,404 $357K
74176 Computed tomography, abdomen and pelvis; without contrast material 969 876 $346K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2,904 1,200 $257K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 8,692 7,489 $242K
90853 Group psychotherapy (other than of a multiple-family group) 7,534 1,199 $183K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,767 1,379 $149K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 15,116 12,402 $135K
80053 Comprehensive metabolic panel 12,662 10,848 $127K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 3,594 1,100 $117K
77067 Screening mammography, bilateral, including computer-aided detection 1,122 1,077 $113K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,992 4,399 $104K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,252 2,629 $104K
71046 Radiologic examination, chest; 2 views 3,348 3,126 $94K
71045 Radiologic examination, chest; single view 4,089 3,665 $94K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,218 1,837 $87K
76700 Ultrasound, abdominal, real time with image documentation; complete 463 435 $77K
96361 Intravenous infusion, hydration; each additional hour 3,651 3,224 $74K
72125 Computed tomography, cervical spine; without contrast material 477 409 $68K
76830 Ultrasound, transvaginal 373 361 $64K
OP250 32,676 14,370 $63K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 328 324 $58K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 818 289 $55K
OP710 601 485 $51K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,590 2,567 $48K
84484 5,145 4,222 $45K
77063 Screening digital breast tomosynthesis, bilateral 1,113 1,067 $42K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 602 580 $37K
71275 Computed tomographic angiography, chest, with contrast material 156 140 $37K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 138 77 $36K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 927 749 $35K
93017 55 53 $32K
97162 580 535 $30K
OP272 6,551 4,829 $30K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 177 76 $29K
36415 Collection of venous blood by venipuncture 15,950 13,365 $28K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 193 182 $28K
OP270 6,233 3,596 $27K
96376 740 530 $27K
97161 488 433 $23K
84443 Thyroid stimulating hormone (TSH) 2,040 1,853 $19K
80048 Basic metabolic panel (calcium, ionized) 3,242 2,709 $19K
76641 104 100 $18K
81001 6,541 5,931 $18K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,033 986 $17K
81025 3,810 3,589 $15K
71250 108 91 $15K
83690 3,681 3,333 $14K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 595 503 $14K
71260 Computed tomography, thorax, diagnostic; with contrast material 57 54 $13K
83735 3,665 3,143 $13K
85610 4,482 3,883 $13K
84145 921 806 $12K
85730 3,970 3,574 $12K
83880 1,077 931 $11K
73610 320 296 $11K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 484 464 $9K
73630 263 245 $9K
86850 802 665 $8K
73030 205 183 $7K
99281 Emergency department visit for the evaluation and management, self-limited or minor 127 122 $7K
87486 330 326 $7K
87581 330 326 $7K
83605 1,180 1,010 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 332 328 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 267 259 $6K
82962 2,587 1,890 $6K
87040 707 637 $6K
0012A 209 208 $6K
76536 42 38 $6K
0011A 209 209 $5K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 219 149 $5K
OP258 5,265 2,131 $5K
0004A 140 140 $5K
86901 854 705 $5K
J1756 Injection, iron sucrose, 1 mg 136 49 $5K
OP259 2,921 1,144 $5K
80076 1,144 1,029 $4K
86900 864 717 $4K
84702 434 404 $4K
87631 59 59 $4K
87086 Culture, bacterial; quantitative colony count, urine 899 818 $3K
85378 895 816 $3K
80061 Lipid panel 636 572 $3K
73564 81 73 $3K
OP279 327 317 $3K
82077 491 410 $3K
0001A 93 93 $3K
0002A 97 97 $3K
81003 1,009 954 $3K
84100 1,567 1,360 $3K
73130 89 79 $3K
OP370 14 13 $3K
80143 358 298 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,573 2,091 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,488 2,223 $2K
90791 Psychiatric diagnostic evaluation 44 36 $2K
72100 44 39 $2K
80179 327 273 $2K
A4215 Needle, sterile, any size, each 527 501 $2K
76770 15 13 $2K
0064A 66 66 $2K
J7030 Infusion, normal saline solution , 1000 cc 3,264 2,517 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 325 322 $2K
84703 412 393 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 49 39 $2K
82550 438 396 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 138 135 $2K
77080 13 13 $2K
93971 14 12 $2K
J3490 Unclassified drugs 2,945 1,842 $2K
93041 170 167 $1K
97165 42 38 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 118 116 $1K
96367 54 39 $1K
93970 12 12 $1K
90715 125 120 $1K
85027 433 355 $1K
0071A 32 32 $1K
76705 Ultrasound, abdominal, real time with image documentation; limited 12 12 $1K
0072A 30 30 $1K
73562 30 27 $1K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 32 25 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 926 720 $842.94
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 5,874 4,110 $842.72
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15 12 $831.75
83036 Hemoglobin; glycosylated (A1C) 334 293 $794.83
90834 Psychotherapy, 45 minutes with patient 14 12 $759.52
80320 44 42 $729.95
J2704 Injection, propofol, 10 mg 212 189 $708.64
76857 14 14 $628.00
73110 24 24 $612.59
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 141 137 $609.04
J0696 Injection, ceftriaxone sodium, per 250 mg 123 62 $561.09
74018 14 12 $505.42
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 118 116 $502.17
J0131 Injection, acetaminophen, not otherwise specified,10 mg 317 304 $494.13
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 219 201 $382.43
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 139 115 $355.11
83789 82 66 $352.34
80305 35 25 $332.64
82552 79 76 $307.81
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 14 12 $285.64
J7050 Infusion, normal saline solution, 250 cc 361 195 $282.18
87077 79 66 $167.31
87430 29 28 $143.72
J1170 Injection, hydromorphone, up to 4 mg 178 127 $137.33
87186 45 36 $96.59
86140 57 40 $93.82
OP255 97 60 $89.89
J1200 Injection, diphenhydramine hcl, up to 50 mg 249 194 $77.27
85652 97 62 $55.83
85379 13 13 $54.50
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 105 68 $43.60
83615 14 12 $38.64
J2060 Injection, lorazepam, 2 mg 102 76 $36.23
87070 12 12 $27.90
J2270 Injection, morphine sulfate, up to 10 mg 93 71 $26.76
J2765 Injection, metoclopramide hcl, up to 10 mg 68 59 $17.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 37 26 $8.00
J2250 Injection, midazolam hydrochloride, per 1 mg 13 13 $5.00
81002 27 27 $4.20
J3010 Injection, fentanyl citrate, 0.1 mg 15 12 $0.85